One problem in the development and refinement of anti-venoms is ascertaining both overall anti-venom reactivity and which key toxins are neutralized. Here we show by SE-HPLC that the in vitro reaction of CroFab anti-venin with Crotalus atrox venom asymptotically nears completion (>95%) by 11 min at 4 degrees C by following the change in area under chromatographic peaks. The peaks for reactants decrease and the formation of high molecular weight complexes increases with time. To assay the large number of samples a new microplate format phospholipase A(2) (PLA(2)) assay at an initial pH of 7.5 was developed using phosphotidyl choline as the substrate. The change in absorbance is due to the pH change caused by release of fatty acids, and is linear with dilution of enzyme. This choice of substrate limits detection to PLA(2) and nonspecific esterase (if any) activities. The neutralization mixtures show a dose dependent (CroFab anti-venin) inactivation of C. atrox PLA(2) activity approaching a maximum of 85% neutralization. This approach of revealing antibody binding to venom components coupled with enzyme activity measurements is effective and may lead to greater in vitro assessment of antivenin activity in product development, and less routine use of mouse lethality assays.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.toxicon.2006.12.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Antivenom Administration After Rattlesnake Envenoming in Arizona Does Not Directly Diminish Pain.
Toxins (Basel)
December 2024
Poison Control Center, The University of Arizona College of Pharmacy, Tucson, AZ 85724, USA.
The onset, progression, and severity of pain following rattlesnake envenomation are highly variable between patients. Pain can be severe and persistent, seemingly refractory to opioid analgesics. The ability of antivenom to directly relieve pain has not been well studied.
View Article and Find Full Text PDFWestern Pygmy Rattlesnake Envenomation and Bite Management.
Cutis
October 2024
Department of Orthopaedic Surgery, University of Illinois Chicago.
Article Synopsis
- The western pygmy rattlesnake is a small but dangerous snake native to several U.S. states, including Missouri and Tennessee.
- Bites from this snake can lead to serious health issues like hospitalization and tissue damage.
- A case study highlights a 56-year-old man who was bitten and required antivenom treatment and prolonged wound care.
Acute adverse effects of F(ab')₂AV and FabAV use for rattlesnake Envenomations: A four-year poison center study.
Am J Emerg Med
January 2025
Department of Emergency Medicine, UC San Diego Health, San Diego, CA, USA; San Diego Division, California Poison Control System, San Diego, CA, USA.
Article Synopsis
- Rattlesnake envenomations are common in the U.S., with two main antivenoms available: CroFab® and ANAVIP®.
- A study reviewed 481 cases of rattlesnake bites treated with these antivenoms between 2018 and 2022, focusing on adverse effects.
- Results show that CroFab® had a higher rate of severe adverse events (1.5%) compared to ANAVIP®, which had none, indicating that both antivenoms are generally safe but ANAVIP® may have a better safety profile.
A case of Western Gaboon viper (Bitis rhinoceros) envenomation: Successful treatment with South African Institute for Medical Research (SAIMR) antivenom after North American crotalid antivenom failure.
Toxicon
November 2024
Department of Emergency Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY, 10461, USA.
Article Synopsis
- A 59-year-old man suffered from Western Gaboon viper (Bitis rhinoceros) envenomation, initially treated with North American crotalid antivenom, which proved ineffective.
- He experienced worsening symptoms, including swelling and low platelet counts, prompting a transfer to a facility that provided South African Institute for Medical Research (SAIMR) polyvalent antivenom.
- After receiving the appropriate antivenom, the patient's condition rapidly improved, demonstrating the importance of using species-specific antivenom for viper bites and consulting poison centers for proper treatment guidance.*
Characterization of hypofibrinogenemia following rattlesnake envenomation treated with crotalidae immune F(ab') (equine) antivenom.
Clin Toxicol (Phila)
November 2024
Arizona Poison and Drug Information Center, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Introduction: Hemotoxicity is common following rattlesnake envenomation. Published experiences with equine-derived crotalidae immune F(ab') antivenom have characterized hemotoxicity as delayed, recurrent, or persistent. This study investigated recovery of hypofibrinogenemia following rattlesnake envenomation treated with equine-derived crotalidae immune F(ab') antivenom.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!